Catalogue Number
CT220
Description
mAb anti-human IFN-γ FITC (MD-1) - 50 µg
Price
€ 385.00
Characteristics
clone MD-1 (FITC)
Summary
The monoclonal antibody to human IFN-γ (clone MD-1) was first described in 1985. It has shown to neutralize the antiviral activity of both natural and recombinant human IFN-γ and in a Western Blot the antibody reacts with the 20 kDa and 25 kDa polypeptides present in natural human IFN-γ (van der Meide P.H. et al. 1985). The antibody has proven to cross react with chimpanzee and rhesus macaque IFN-γ and can be used for immunohistochemical staining of frozen tissues (Jonker M. et al. 2013 and Kap Y. et al. 2009). The MD-1 antibody has been reported for use in intracellular flow cytometric analysis (Hamann D. et al. 1996). Other available formats: unconjugated (cat. no. CT215) and biotin labeled (cat. no. CT218).
References list
- Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19.
- CD30 expression does not discriminate between human Th1- and Th2-type T cells.
- Comparative analysis of inflammatory infiltrates in collagen-induced arthritis, kidney graft rejection and delayed-type hypersensitivity in non-human primates.
- A monoclonal antibody selection for immunohistochemical examination of lymphoid tissues from non-human primates.
- Herpesvirus trigger accelerates neuroinflammation in a nonhuman primate model of multiple sclerosis.
- A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C.
- Monoclonal antibodies to human immune interferon and their use in a sensitive solid-phase ELISA.